Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.

Publication Type:
Journal Article
Year of Publication:
Journal:
Toxicol Appl Pharmacol
Date Published:
Abstract:

Utilizing the atto-zeptomole sensitivity of UPLC-accelerator mass spectrometry (UPLC-AMS), we previously demonstrated significant first-pass metabolism following escalating (25-250 ng) oral micro-dosing in humans of [<sup>14</sup>C]-benzo[a]pyrene ([<sup>14</sup>C]-BaP). The present study examines the potential for supplementation with Brussels sprouts (BS) or 3,3'-diindolylmethane (DIM) to alter plasma levels of [<sup>14</sup>C]-BaP and metabolites over a 48-h period following micro-dosing with 50 ng (5.4 nCi) [<sup>14</sup>C]-BaP. Volunteers were dosed with [<sup>14</sup>C]-BaP following fourteen days on a cruciferous vegetable restricted diet, or the same diet supplemented for seven days with 50 g of BS or 300 mg of BR-DIM® prior to dosing. BS or DIM reduced total [<sup>14</sup>C] recovered from plasma by 56-67% relative to non-intervention. Dietary supplementation with DIM markedly increased T<sub>max</sub> and reduced C<sub>max</sub> for [<sup>14</sup>C]-BaP indicative of slower absorption. Both dietary treatments significantly reduced C<sub>max</sub> values of four downstream BaP metabolites, consistent with delaying BaP absorption. Dietary treatments also appeared to reduce the T<sub>1/2</sub> and the plasma AUC(<sub>0,∞</sub>) for Unknown Metabolite C, indicating some effect in accelerating clearance of this metabolite. Toxicokinetic constants for other metabolites followed the pattern for [<sup>14</sup>C]-BaP (metabolite profiles remained relatively consistent) and non-compartmental analysis did not indicate other significant alterations. Significant amounts of metabolites in plasma were at the bay region of [<sup>14</sup>C]-BaP irrespective of treatment. Although the number of subjects and large interindividual variation are limitations of this study, it represents the first human trial showing dietary intervention altering toxicokinetics of a defined dose of a known human carcinogen.

DOI:
10.1016/j.taap.2023.116377
PubMed ID:
36642108
PubMed Central ID:
PMC9946811
Funding Sources
R01 ES028600
P30 ES030287
R24 GM137748
P42 ES016465
T32 ES007060